COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)

Background: Vaccinations against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are intended to induce an immune response to protect against infection/disease. Allergen immunotherapy (AIT) is thought to induce a (different) immune response, e.g., to induce tolerance to allergens....

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, Ludger, Pfaar, Oliver, Hamelmann, Eckard, Kleine-Tebbe, Jörg, Taube, Christian , Wagenmann, Martin, Werfel, Thomas, Brehler, Randolf, Novak, Natalija , Mülleneisen, Norbert, Becker, Sven, Worm, Margitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2021
Materias:
Position Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439106/
https://www.ncbi.nlm.nih.gov/pubmed/34533543
http://dx.doi.org/10.5414/ALX02245E

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439106/
https://www.ncbi.nlm.nih.gov/pubmed/34533543
http://dx.doi.org/10.5414/ALX02245E

Ejemplares similares